PTP on Frankfurt Stock Exchange

Pentixapharm

Logo: pentixapharm.com3

Pentixapharm is a joint-stock company registered in Germany, part of Pentixapharm Holding AG.1 Its website says: “Pentixapharm is a radiopharmaceutical development company founded in 2019, with its headquarters in Würzburg, Germany. It is committed to develop the innovative theranostic pair PentixaFor and PentixaTher, two small peptide-based radiopharmaceuticals that specifically target the CXCR4-receptor.”3 It was founded by Eckert & Ziegler Group.1 Its chief executive is Hakim Bouterfa.1 It employed 80 people.1 Its shares trade on Frankfurt Stock Exchange under the symbol PTP.1

Price unavailable

Last updated Oct 21, 2026.

Overview

2019Founded1

Compare with another stock.

  • TickerPTP on Frankfurt Stock Exchange1
  • HeadquartersWürzburg, Germany1
  • Websitewww.pentixapharm.com
  • Legal formAktiengesellschaft1
  • LEI8945005LJQ46NWH305922
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressRobert-Rössle-Str. 10, 13125 Berlin, Germany2
  • Registered withLocal Court Berlin-Charlottenburg, HRB 2699132

Corporate structure

Pentixapharm is part of a group headed by Pentixapharm Holding AG. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.

The story

Founded by Eckert & Ziegler Group in 2019.1

Leadership

Who has led Pentixapharm, and when. Pick a name to see everywhere that person has worked.

Subsidiaries and ownership

Parent company (GLEIF)

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Timeline

  1. Oct 23, 2024Parent Directly consolidated by Pentixapharm Holding AG2
  2. 2019Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
    Company websitePentixapharm logo